NOV.DE vs. CSP1.L
Compare and contrast key facts about Novo Nordisk A/S (NOV.DE) and iShares Core S&P 500 UCITS ETF (CSP1.L).
CSP1.L is a passively managed fund by iShares that tracks the performance of the S&P 500 Index. It was launched on May 19, 2010.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NOV.DE or CSP1.L.
Key characteristics
| NOV.DE | CSP1.L | |
|---|---|---|
| YTD Return | 14.47% | 24.75% |
| 1Y Return | 12.18% | 31.48% |
| 3Y Return (Ann) | 38.25% | 11.74% |
| 5Y Return (Ann) | 46.96% | 15.49% |
| 10Y Return (Ann) | 42.64% | 15.39% |
| Sharpe Ratio | 0.47 | 2.77 |
| Sortino Ratio | 0.91 | 3.95 |
| Omega Ratio | 1.11 | 1.54 |
| Calmar Ratio | 0.55 | 4.93 |
| Martin Ratio | 1.53 | 19.60 |
| Ulcer Index | 9.54% | 1.58% |
| Daily Std Dev | 30.71% | 11.12% |
| Max Drawdown | -50.94% | -25.48% |
| Current Drawdown | -26.37% | 0.00% |
Correlation
The correlation between NOV.DE and CSP1.L is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NOV.DE vs. CSP1.L - Performance Comparison
In the year-to-date period, NOV.DE achieves a 14.47% return, which is significantly lower than CSP1.L's 24.75% return. Over the past 10 years, NOV.DE has outperformed CSP1.L with an annualized return of 42.64%, while CSP1.L has yielded a comparatively lower 15.39% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NOV.DE vs. CSP1.L - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOV.DE) and iShares Core S&P 500 UCITS ETF (CSP1.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NOV.DE vs. CSP1.L - Dividend Comparison
NOV.DE's dividend yield for the trailing twelve months is around 1.34%, while CSP1.L has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOV.DE Novo Nordisk A/S | 1.34% | 1.01% | 1.18% | 1.27% | 1.99% | 2.09% | 5.96% | 2.28% | 3.69% | 1.25% | 1.69% | 1.82% |
CSP1.L iShares Core S&P 500 UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
NOV.DE vs. CSP1.L - Drawdown Comparison
The maximum NOV.DE drawdown since its inception was -50.94%, which is greater than CSP1.L's maximum drawdown of -25.48%. Use the drawdown chart below to compare losses from any high point for NOV.DE and CSP1.L. For additional features, visit the drawdowns tool.
Volatility
NOV.DE vs. CSP1.L - Volatility Comparison
Novo Nordisk A/S (NOV.DE) has a higher volatility of 3.97% compared to iShares Core S&P 500 UCITS ETF (CSP1.L) at 3.48%. This indicates that NOV.DE's price experiences larger fluctuations and is considered to be riskier than CSP1.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.